BCM
AFIB

Bayesian Capital Management’s Acutus Medical Inc AFIB Stock Holding History

Bayesian Capital Management’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,672
Closed -$12K – 1078
2022
Q2 		$12K Buy
+10,672
New +$9.16K ﹤0.01% 739

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bayesian Capital Management's AFIB Position: Q3 2022 in Review

Bayesian Capital Management sold out of Acutus Medical Inc (AFIB) in Q3 2022, closing a stake of 10,672 shares — an estimated $12K sold.

Bayesian Capital Management first reported a position in AFIB in Q2 2022 and held it in 1 quarter. The position peaked at $12K in Q2 2022. 37 funds tracked by Wall St. Rank hold AFIB as of Q3 2022.

  • Bayesian Capital Management reported no remaining Acutus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 10,672 Acutus Medical Inc shares in Q3 2022, an estimated $12K.
  • Bayesian Capital Management first reported a position in Acutus Medical Inc in Q2 2022 and held it in 1 quarter.
  • Bayesian Capital Management's Acutus Medical Inc position peaked at $12K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.